Risk factors for encephalitis and death from West Nile virus infection

被引:118
作者
Murray, K.
Baraniuk, S.
Resnick, M.
Arafat, R.
Kilborn, C.
Cain, K.
Shallenberger, R.
York, T. L.
Martinez, D.
Hellums, J. S.
Hellums, D.
Malkoff, M.
Elgawley, N.
McNeely, W.
Khuwaja, S. A.
Tesh, R. B.
机构
[1] Univ Texas, Sch Publ Hlth, Houston, TX USA
[2] Univ Texas, Med Branch, Galveston, TX 77550 USA
[3] City Houston Dept Hlth & Human Serv, Houston, TX USA
[4] Harris Cty Publ Hlth & Environm Serv, Houston, TX USA
[5] Univ Texas, Sch Med, Houston, TX USA
[6] Baylor Coll Med, Houston, TX 77030 USA
关键词
D O I
10.1017/S0950268806006339
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We conducted a nested case-control study to determine potential risk factors for developing encephalitis from West Nile virus (WNV) infection. Retrospective medical chart reviews were completed for 172 confirmed WNV cases hospitalized in Houston between 2002 and 2004. Of these cases, 113 had encephalitis, including 17 deaths, 47 had meningitis, and 12 were fever cases; 67% were male. Homeless patients were more likely to be hospitalized from WNV compared to the general population. A multiple logistic regression model identified age [odds ratio (OR) 1.1, P < 0.001], history of hypertension, including those cases taking hypertension-inducing drugs (OR 2.9, P=0.012), and history of cardiovascular disease (OR 3.5, P=0.061) as independent risk factors for developing encephalitis from WNV infection. After adjusting for age, race/ethnicity (being black) (OR 12.0, P < 0.001), chronic renal disease (OR 10.6, P < 0.001), hepatitis C virus (OR 23.1, P = 0.0013), and immunosuppression (OR 3.9, P=0.033) were identified as risk factors for death from WNV infection.
引用
收藏
页码:1325 / 1332
页数:8
相关论文
共 19 条
[1]  
Asnis DS, 2001, ANN NY ACAD SCI, V951, P161
[2]   Stress responses and innate immunity: aging as a contributory factor [J].
Butcher, SK ;
Lord, JM .
AGING CELL, 2004, 3 (04) :151-160
[3]   West Nile virus [J].
Campbell, GL ;
Marfin, AA ;
Lanciotti, RS ;
Gubler, DJ .
LANCET INFECTIOUS DISEASES, 2002, 2 (09) :519-529
[4]  
Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P845
[5]   Diabetes and hypertension physiopathology and therapeutics [J].
Contreras, F ;
Rivera, M ;
Vasquez, J ;
De la Parte, MA ;
Velasco, M .
JOURNAL OF HUMAN HYPERTENSION, 2000, 14 (Suppl 1) :S26-S31
[6]   West Nile Virus [J].
Craven, RB ;
Roehrig, JT .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (06) :651-653
[7]  
Frishman William H, 2003, Heart Dis, V5, P253, DOI 10.1097/01.hdx.0000080713.09303.a6
[8]  
Hosmer W., 2000, Applied Logistic Regression, VSecond
[9]  
Kannel William B, 2002, J Gend Specif Med, V5, P27
[10]   Effect of losartan on the blood-brain barrier permeability in diabetic hypertensive rats [J].
Kaya, M ;
Kalayci, R ;
Küçük, M ;
Arican, N ;
Elmas, I ;
Kudat, H ;
Korkut, F .
LIFE SCIENCES, 2003, 73 (25) :3235-3244